OCT 24, 2019 9:59 PM PDT

Converting Wood into Pharmaceutical Compounds

WRITTEN BY: Nouran Amin

Producing toxic byproducts during the making of pharmaceuticals remains a challenge in the drug manufacturing industry. Normally, increased masses of flammable solvents are utilized during the making of structurally complex drug compounds that consist of several steps.

Scientists have reported their research findings in the journal ACS Central Science. These findings explain a new way to develop pharmaceutically relevant compounds in fewer and more efficient steps with no hazardous materials. The method uses renewable woodchips as the starting material with water as the byproduct. The manufacturing process will take advantage of phenolic compounds found in wood preferably known as lignin and gives wood its known strength.

When making paper, lignin is removed from wood preventing the paper from yellowing and increasing the strength. The remaining lignin is often found in large and unwanted amounts—this made researchers curious to repurpose instead of letting the lignin to go to waste.

Other researchers have utilized lignin through depolymerization. However, these strategic efforts have left scientists curious to see what benefits can be retrieved from this compound?

So, they focused on lignin derivatives because they make ideal starting materials and have similar structural complex chemistry to modern drug compounds. The lignin derivatives make ideal starting materials to synthesize potential pharmaceuticals.

The research team focused on a class of drugs called benzazepines that includes the anti-anxiety therapeutic diazepam. The traditional way of making these drugs includes the generation of toxic waste. But, the catalytic method combines solvents with recyclables and eventually converts monomers from lignin into the benzazepine derivatives without any hazardous byproducts.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 27, 2020
Cannabis Sciences
THC Shows Promise in Treating Severe Cases of COVID-19
SEP 27, 2020
THC Shows Promise in Treating Severe Cases of COVID-19
Over the last few months, various headlines have emerged suggesting the potential for cannabinoids, and in particular, c ...
OCT 27, 2020
Cardiology
Boron Could Prevent Myocardial Fibrosis and Assist in Recovery
OCT 27, 2020
Boron Could Prevent Myocardial Fibrosis and Assist in Recovery
When you pass by the nutrition section at the local grocery store, there is a chance you’ll come across row upon r ...
OCT 10, 2020
Drug Discovery & Development
Fishnet of Nanoparticles Traps Drug Molecules
OCT 10, 2020
Fishnet of Nanoparticles Traps Drug Molecules
‘Fishnet’ Nanoparticles Traps Drug Molecules A team at Northwestern University have casted a net of nanopart ...
NOV 08, 2020
Drug Discovery & Development
Psychedelic Mushrooms Effectively Treat Major Depression
NOV 08, 2020
Psychedelic Mushrooms Effectively Treat Major Depression
Over 17 million people in the US and 300 million people worldwide are estimated to have experienced major depression. No ...
NOV 08, 2020
Cannabis Sciences
Can Cannabis Treat Epilepsy?
NOV 08, 2020
Can Cannabis Treat Epilepsy?
There has been growing interest in recent years for cannabis to treat central nervous system disorders. And so far, ther ...
NOV 02, 2020
Drug Discovery & Development
Potential Therapy for Alzheimer Disease
NOV 02, 2020
Potential Therapy for Alzheimer Disease
A main characteristic of Alzheimer disease is an aggregate of a protein (peptide) clump in the brain leading to memory l ...
Loading Comments...